NewsBenzingaSmith+Nephew Q3 Revenue Rises 3.4% YoY To $1.551B; $250M Of $500M Buyback Completed; Confirms Johnson & Johnson Talks Ended, Still Exploring Orthopaedics Strategic Options Smith+Nephew Q3 Revenue Rises 3.4% YoY To $1.551B; $250M Of $500M Buyback Completed; Confirms Johnson & Johnson Talks Ended, Still Exploring Orthopaedics Strategic Options Benzinga 2026.11.04 07:24 (GMT+0) Open on Benzinga Other news What Are Wall Street Analysts' Target Price for American International Group Stock? Baxter International Stock: Analyst Estimates & Ratings Merck & Co. Stock: Is Wall Street Bullish or Bearish? Stock Market Today: Dow Jones, S&P 500 Futures Rise as Democrats Take Control of Congress—AMD, AMGN, NVO in Focus Needham Maintains Buy on Duolingo, Raises Price Target to $165 Ares Capital Stock: The Dividend Squeeze Is On (NASDAQ:ARCC)
Stock Market Today: Dow Jones, S&P 500 Futures Rise as Democrats Take Control of Congress—AMD, AMGN, NVO in Focus
